Triacylglycerol-rich lipoprotein margination: a potential surrogate for whole-body lipoprotein lipase activity and effects of eicosapentaenoic and docosahexaenoic acids.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  American Journal of Clinical Nutrition

• Publication date

  2004-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1093/AJCN/80.1.45PMID 15213026
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance Published, JLR Papers in Press, December 1, 2002. DOI 10.1194/jlr.M200282-JLR200

  2003cited by this paper
• Eicosapentaenoic acid induces mRNA expression of peroxisome proliferator-activated receptor gamma.

  2002cited by this paper
• Activity and concentration of lipoprotein lipase in post-heparin plasma and the extent of coronary artery disease.

  2002cited by this paper
• Association between preheparin serum lipoprotein lipase mass and acute myocardial infarction in Japanese men.

  2002cited by this paper
• Dietary long-chain n-3 PUFAs increase LPL gene expression in adipose tissue of subjects with an atherogenic lipoprotein phenotype.

  2002cited by this paper
• Invited Review: Lipoprotein Lipase and Triglyceride-Rich Lipoprotein Metabolism

  2001cited by this paper
• Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids.

  2001cited by this paper
• Measurement of human chylomicron triglyceride clearance with a labeled commercial lipid emulsion

  2001cited by this paper
• Differential transcriptional activation of peroxisome proliferator-activated receptor gamma by omega-3 and omega-6 fatty acids in MCF-7 cells.

  2000cited by this paper
• Activation of PPARδ alters lipid metabolism in db/db mice

  2000cited by this paper
• A new method for the study of chylomicron kinetics in vivo.

  2000cited by this paper
• Preheparin serum lipoprotein lipase mass is negatively related to coronary atherosclerosis.

  2000cited by this paper
• Activation of PPARdelta alters lipid metabolism in db/db mice.

  2000cited by this paper
• Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease.

  1999cited by this paper
• Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester.

  1999cited by this paper
• Lipoprotein lipase activity is decreased in a large cohort of patients with coronary artery disease and is associated with changes in lipids and lipoproteins.

  1999cited by this paper
• Moderate Intake of n-3 Fatty Acids for 2 Months Has No Detrimental Effect on Glucose Metabolism and Could Ameliorate the Lipid Profile in Type 2 Diabetic Men: Results of a controlled study

  1998cited by this paper
• Prevention of diet-induced obesity in transgenic mice overexpressing skeletal muscle lipoprotein lipase.

  1997cited by this paper
• Chylomicron/chylomicron remnant turnover in humans: evidence for margination of chylomicrons and poor conversion of larger to smaller chylomicron remnants.

  1997cited by this paper
• N-3 fatty acids and chylomicron metabolism in the rat.

  1997cited by this paper
• Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases.

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: human studies.

  1997cited by this paper
• The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial.

  1997cited by this paper
• n-3 fatty acids and serum lipoproteins: animal studies.

  1997cited by this paper
• Chylomicron metabolism in rats: lipolysis, recirculation of triglyceride-derived fatty acids in plasma FFA, and fate of core lipids as analyzed by compartmental modelling.

  1996cited by this paper
• Lipoprotein lipase mass and activity in plasma and their increase after heparin are separate parameters with different relations to plasma lipoproteins.

  1995cited by this paper
• Association of postprandial triglyceride and retinyl palmitate responses with asymptomatic carotid artery atherosclerosis in middle-aged men and women. The Atherosclerosis Risk in Communities (ARIC) Study.

  1995cited by this paper
• Measurement and physiological significance of lipoprotein and hepatic lipase activities in preheparin plasma.

  1995cited by this paper
• Postprandial lipoprotein lipase, insulin and gastric inhibitory polypeptide responses to test meals of different fatty acid composition: comparison of saturated, n-6 and n-3 polyunsaturated fatty acids.

  1994cited by this paper
• Postprandial lipoproteins and progression of coronary atherosclerosis.

  1994cited by this paper
• Beneficial effects of fish-oil supplements on lipids, lipoproteins, and lipoprotein lipase in patients with glycogen storage disease type I.

  1993cited by this paper
• Lipoprotein lipase in human plasma is mainly inactive and associated with cholesterol-rich lipoproteins.

  1993cited by this paper
• Fish oil reduces postprandial triglyceride concentrations without accelerating lipid-emulsion removal rates.

  1993cited by this paper
• Modification of lipid-related atherosclerosis risk factors by ω3 fatty acid ethyl esters in hypertriglyceridemic patients

  1993cited by this paper
• Preheparin lipoprotein lipolytic activities: relationship to plasma lipoproteins and postheparin lipolytic activities.

  1992cited by this paper
• Lipoprotein lipase in plasma after an oral fat load: relation to free fatty acids.

  1992cited by this paper
• Lipoprotein lipase enhances binding of lipoproteins to heparan sulfate on cell surfaces and extracellular matrix.

  1992cited by this paper
• The effects of fish oil on triglycerides, cholesterol, fibrinogen and malondialdehyde in humans supplemented with vitamin E.

  1991cited by this paper
• Short-term effects of fish oil on human plasma lipid levels

  1991cited by this paper
• Use of Plasma Lipoprotein Lipase Activity without Heparin Injection for Detection of Homozygous and Heterozygous Lipoprotein Lipase Deficiency

  1991cited by this paper
• Lipoprotein lipase and hepatic lipase

  1991cited by this paper
• Postheparin lipolytic activity and plasma lipoprotein response to omega-3 polyunsaturated fatty acids in patients with primary hypertriglyceridemia.

  1991cited by this paper
• N-3 fatty acid supplements reduce chylomicron levels in healthy volunteers

  1991cited by this paper
• Fish oils in hypertriglyceridemia: a dose-response study.

  1990cited by this paper
• Hypotriglyceridemic action of omega-3 fatty acids in healthy subjects does not occur by enhanced lipoprotein lipase and hepatic lipase activities.

  1989cited by this paper
• Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases.

  1989influential reference
• Plasma Lipolytic Activity: Relationship to Postheparin Lipolytic Activity and Evidence for Metabolic Regulation

  1988cited by this paper
• Dietary polyunsaturated fats of the W-6 and W-3 series reduce postprandial lipoprotein levels. Chronic and acute effects of fat saturation on postprandial lipoprotein metabolism.

  1988cited by this paper
• Reduction of postprandial triglyceridemia in humans by dietary n-3 fatty acids.

  1988cited by this paper
• Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.

  1986cited by this paper
• Human adipose tissue lipoprotein lipase: changes with feeding and relation to postheparin plasma enzyme.

  1985cited by this paper
• Simple, reproducible procedure for selective measurement of lipoprotein lipase and hepatic lipase.

  1983cited by this paper
• The effects of salmon oil upon plasma lipids, lipoproteins, and triglyceride clearance.

  1980cited by this paper
• A new method for the measurement of lipoprotein lipase in postheparin plasma using sodium dodecyl sulfate for the inactivation of hepatic triglyceride lipase.

  1979cited by this paper
• Differential characteristics of purified hepatic triglyceride lipase and lipoprotein lipase from human postheparin plasma.

  1977cited by this paper
• Chylomicron clearance in normal and hyperlipidemic man.

  1976cited by this paper
• Kinetics of chylomicron triglyceride removal from plasma in rats: effect of dose on the volume of distribution.

  1973cited by this paper

• Icosapent ethyl–induced lipoprotein remodeling and its impact on cardiovascular disease risk markers in normolipidemic individuals

  2025influential citation
• The differential effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors: an updated systematic review of randomized controlled trials

  2024cites this paper
• Omega-3 fatty acid regulation of lipoprotein lipase and FAT/CD36 and its impact on white adipose tissue lipid uptake

  2024influential citation
• Lipoprotein Lipase Activity Does Not Differ in the Serum Environment of Vegans and Omnivores

  2023influential citation
• Association of Fish and Omega-3 Fatty Acid Intake with Carotid Intima-Media Thickness in Middle-Aged to Elderly Japanese Men and Women: The Toon Health Study

  2022cites this paper
• Lipid-Lowering Therapy in Women of Childbearing Age: a Review and Stepwise Clinical Approach

  2022cites this paper
• Comparative Analysis of the Effects of Fish Oil and Fenofibrate on Plasma Metabolomic Profiles in Overweight and Obese Individuals

  2021cites this paper
• Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date

  2020cites this paper
• VHRM_A_210149 1..10

  2020cites this paper
• Principal Component Analysis of Stimulatory Effect of Synbiotic Combination of Indigenous Probiotic and Inulin on Antioxidant Activity of Soymilk

  2019cites this paper
• Eicosapentaenoic acid and docosahexaenoic acid containing supplements modulate risk factors for cardiovascular disease: a meta‐analysis of randomised placebo‐control human clinical trials

  2018cites this paper
• The Differential Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Cardiometabolic Risk Factors: A Systematic Review

  2018influential citation
• Different postprandial metabolic patterns after the consumption of fish oil and lard in healthy Chinese individuals

  2017cites this paper
• Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review

  2017influential citation
• Estratégias para as opções dietéticas de combate à obesidade relacionadas com a morbilidade cardiometabolica

  2017cites this paper
• Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.

  2017cites this paper
• Omega-3 Polyunsaturated Fatty Acids and Hyperlipidaemias

  2016cites this paper
• Challenges in enriching milk fat with polyunsaturated fatty acids

  2015cites this paper
• Omega-3 fatty acids improve postprandial lipemia and associated endothelial dysfunction in healthy individuals - a randomized cross-over trial.

  2014cites this paper
• Efeito do pré-tratamento com óleo de peixe sobre o infarto agudo do miocárdio em ratos.

  2014cites this paper
• Antioxidant activity and viability of lactic acid bacteria in soybean-yogurt made from cow and camel milk

  2013cites this paper
• Mammary Uptake of Fatty Acids Supplied by Intravenous Triacylglycerol Infusion to Lactating Dairy Cows

  2013cites this paper
• How does it reduce plasma triglycerides ? ☆ ☆ ☆

  2012cites this paper
• Fish oil -- how does it reduce plasma triglycerides?

  2012cites this paper
• Systemic and Intracellular Trafficking of Long-chain Fatty Acids in Lactating Dairy Cattle

  2012cites this paper
• A Diet Enriched in Docosahexanoic Acid Exacerbates Brain Parenchymal Extravasation of Apo B Lipoproteins Induced by Chronic Ingestion of Saturated Fats

  2011cites this paper
• Reduction in systemic and VLDL triacylglycerol concentration after a 3-month Mediterranean-style diet in high-cardiovascular-risk subjects.

  2010cites this paper
• Novel factors affecting clearance of triacylglycerol-rich lipoproteins from blood

  2010cites this paper
• n-3, but not n-6 lipid particle uptake requires cell surface anchoring.

  2010cites this paper
• VLDL-TG kinetics: a dual isotope study for quantifying VLDL-TG pool size, production rates, and fractional oxidation in humans.

  2009cites this paper
• Long‐chain n‐3 polyunsaturated fatty acids: new insights into mechanisms relating to inflammation and coronary heart disease

  2009cites this paper
• Dose-Response of n-3 Polyunsaturated Fatty Acids on Lipid Profile and Tolerability in Mildly Hypertriglyceridemic Subjects

  2009cites this paper
• Fish oil in the treatment of dyslipidemia

  2008cites this paper
• Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease.

  2008cites this paper
• Omega-3 fatty acid containing diets decrease plasma triglyceride concentrations in mice by reducing endogenous triglyceride synthesis and enhancing the blood clearance of triglyceride-rich particles.

  2008cites this paper
• Dietary oleic and palmitic acids modulate the ratio of triacylglycerols to cholesterol in postprandial triacylglycerol-rich lipoproteins in men and cell viability and cycling in human monocytes.

  2007cites this paper
• Functional food synergies : improving the effect of the omega-3 fatty acid docosahexaenoic acid on cardiovascular disease risk factors through concurrent dietary consumption of canola or soy isoflavones.

  2007cites this paper
• The effect of high-dose simvastatin on triglyceride-rich lipoprotein metabolism in patients with type 2 diabetes mellitus Published, JLR Papers in Press, October 28, 2005.

  2006cites this paper
• Docosahexaensäure (DHA) und langkettige Omega-3-Fettsäuren: Klinische Bedeutung für das kardiovaskuläre System

  2006cites this paper
• Why do omega-3 fatty acids lower serum triglycerides?

  2006cites this paper
• Dietary Intake of n6 Fatty Acids Modulates Effect of Apolipoprotein A 5 Gene on Plasma Fasting Triglycerides , Remnant Lipoprotein Concentrations , and Lipoprotein Particle Size The Framingham Heart Study

  2006cites this paper
• Triglycerides in fish oil affect the blood clearance of lipid emulsions containing long- and medium-chain triglycerides in mice.

  2006cites this paper
• Omega 3 Fatty Acids

  2006cites this paper
• Dietary Intake of n-6 Fatty Acids Modulates Effect of Apolipoprotein A5 Gene on Plasma Fasting Triglycerides, Remnant Lipoprotein Concentrations, and Lipoprotein Particle Size: The Framingham Heart Study

  2006cites this paper
• THE RELATIONSHIP BETWEEN OMEGA-3 FATTY ACID INTAKE AND RISK OF CARDIOVASCULAR DISEASE A review of a diet-disease relationship prepared for Food Standards Australia New Zealand

  2006cites this paper
• Genetics and molecular biology.

  2005cites this paper
• The Use of Fish Oil Supplements in Clinical Practice: A Review

  2005cites this paper